2013 needs to be a year of major, actionable change in pharma.
I am also writing about creativity squashers in Big Pharma in my mini-series “Are you there, Pharma? It’s me, Liz.”
- Are you there, Pharma? It’s me, Liz. Part One: Listening and Acting (pugtato.com)
- Are you there Pharma? It’s me, Liz. Part two: What’s Killing Creativity in Big Pharma Sales Forces? (pugtato.com)
- 13 digital pharma predictions for 2013 (pharmastrategic.com)
- BulletinHealthcare a TOP 10 “Most Innovative Company” of 2012 According to Pharma Marketing Publication PM360 (prweb.com)
- ‘Bad Pharma’ says we’re all victims of drug industry (engineeringevil.com)
- Pharma Marketing to Physicians for 2012 [INFOGRAPHIC] (medmeme.com)
The familiar rituals of festive celebration can be a comfort to many, and prudent hosts remember that such occasions are not a time for innovation. Family, friends and guests are more likely to enjoy the shared pleasures of participating in a ritual’s traditions than they are to be craving diversion from its norms.
However, beyond a certain point the appeal of the familiar can quickly wane. Not only can we have a surfeit of convention; we can also become thoroughly nauseated by it.
Reviewing some of the customary ‘New Year’s predictions for pharma’ posts on returning to my desk this week, I felt more than a little queasy (this post by Digitally Sick colleague Alex Butler being a notable exception).
Unlike the celebrations that precede it, the New Year is a time to take a fresh look at the problems that confront us, not merely to resume…
View original post 399 more words